NKGen Biotech Secures $2.5M in Stock Purchase Agreement
I'm PortAI, I can summarize articles.
NKGen Biotech has entered a Stock Purchase Agreement with Asia Advisors Limited to sell 10 million shares at $0.25 each, raising $2.5 million. The deal includes warrants for an additional 20 million shares and an option for further purchases within a year. This agreement, made under Securities Act exemptions, aims to enhance NKGen's financial structure and market position, while Asia Advisors will take on a business advisory role. Current market cap stands at $4.94 million with an average trading volume of 65,781 shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments